Related Experiment Video

Updated: May 23, 2026

Curcuminoid-Mediated Antimicrobial Photodynamic Therapy on a Murine Model of Oral Candidiasis
06:39

Curcuminoid-Mediated Antimicrobial Photodynamic Therapy on a Murine Model of Oral Candidiasis

Published on: October 27, 2023

[The modern algorithm for treatment and diagnostics of otomycosis]

    Vestnik Otorinolaringologii
    |March 22, 2012
    PubMed

    Insights

    Fungal ear infections, or otomycosis, represent 25.23% of ear inflammation cases. The study identifies key risk factors, symptoms, and highlights the growing role of non-albicans Candida strains in chronic infections.

    Area of Science:

    • Otolaryngology
    • Mycology
    • Infectious Diseases

    Background:

    • Otomycosis is a significant component of ear infections.
    • Inflammatory ear pathology includes a notable percentage of fungal infections.
    • Understanding otomycosis prevalence is crucial for public health.

    Observation:

    • Analysis of 1762 patients and medical records.
    • Investigation of current scientific literature on otomycosis.
    • Identification of factors contributing to otomycosis development.

    Findings:

    • Fungal otitis accounts for 25.23% of total ear, nose, and throat (ENT) morbidity.
    • Key clinical symptoms and risk factors for otomycosis were identified.
    • Increasing prevalence of non-albicans Candida strains in chronic ENT inflammation.

    Implications:

    • Highlights the need for targeted antifungal treatments.
    • Suggests a shift in etiological agents for chronic fungal ENT infections.
    • Informs clinical practice regarding diagnosis and management of otomycosis.

    More Related Videos

    In Vivo Confocal Microscopy: A Standard Operating Procedure for the Detection of Demodex Mites at the Eyelid Margin05:21

    In Vivo Confocal Microscopy: A Standard Operating Procedure for the Detection of Demodex Mites at the Eyelid Margin

    Published on: July 3, 2025

    Related Concept Videos

    Open Angle Glaucoma: Treatment01:27

    Open Angle Glaucoma: Treatment

    In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
    Drugs such as carbonic anhydrase inhibitors, α2- and...
    Skin Diseases and Disorders01:23

    Skin Diseases and Disorders

    Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
    Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
    Angle Closure Glaucoma: Treatment01:28

    Angle Closure Glaucoma: Treatment

    Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
    Antifungal Agents01:15

    Antifungal Agents

    Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...